Extended anticoagulation after venous thromboembolism: should it be done?

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Citação
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, v.13, article ID 1753466619878550, 13p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Most physicians understand venous thromboembolism (VTE) to be an acute and time-limited disease. However, pathophysiological and epidemiological data suggest that in most patients VTE recurrence risk is not resolved after the first 6 months of anticoagulation. Recurrence rates are high and potentially life-threatening. In these cases, it would make sense to prolong anticoagulation for an undetermined length of time. However, what about the bleeding rates, induced by prolonged anticoagulation? Would they not outweigh the benefit of reducing the VTE recurrent risk? How long should anticoagulation be continued, and should all patients suffering from VTE be provided with extended anticoagulation? This review will address the most recent data concerning extended anticoagulation in VTE secondary prophylaxis. The reviews of this paper are available via the supplementary material section.
Palavras-chave
deep vein thrombosis, direct oral anticoagulants, extended anticoagulation, provoked, pulmonary embolism, treatment, unprovoked, venous thromboembolism
Referências
  1. Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541
  2. Albertsen IE, 2018, CIRCULATION, V138, P2591, DOI 10.1161/CIRCULATIONAHA.118.036548
  3. Andreozzi GM, 2015, CIRCULATION, V132, P1891, DOI 10.1161/CIRCULATIONAHA.115.016930
  4. Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6
  5. BARRITT DW, 1960, LANCET, V1, P1309
  6. Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903
  7. Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238
  8. Blondon M, 2015, CIRCULATION, V132, P1856, DOI 10.1161/CIRCULATIONAHA.115.019310
  9. Bova C, 2016, THROMB RES, V139, P22, DOI 10.1016/j.thromres.2016.01.005
  10. Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384
  11. Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638
  12. Fernandes CJCD, 2017, J BRAS PNEUMOL, V43, P403, DOI [10.1590/S1806-37562017000060002, 10.1590/s1806-37562017000060002]
  13. Fernandes CJCD, 2016, J BRAS PNEUMOL, V42, P146, DOI [10.1590/S1806-37562016042020068, 10.1590/S1806-37562016000000068]
  14. Cimminiello C, 2017, INTERN EMERG MED, V12, P1291, DOI 10.1007/s11739-017-1714-9
  15. Couturaud F, 2016, EUR RESPIR J, V47, P1313, DOI 10.1183/13993003.00212-2016
  16. Couturaud F, 2015, JAMA-J AM MED ASSOC, V314, P31, DOI 10.1001/jama.2015.7046
  17. de Moerloose P, 2001, Semin Vasc Med, V1, P89, DOI 10.1055/s-2001-14545
  18. Douketis J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d813
  19. Douketis J, 2010, ANN INTERN MED, V153, P523, DOI 10.7326/0003-4819-153-8-201010190-00009
  20. Eichinger S, 2008, ARCH INTERN MED, V168, P1678, DOI 10.1001/archinte.168.15.1678
  21. Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214
  22. Fernandes C, 2018, J BRAS PNEUMOL, V44, P180
  23. Fernandes CJ, 2019, RESPIRATION, V98, P253, DOI 10.1159/000501342
  24. Fernandes CJ, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0119-2018
  25. Francis CW, 2015, J THROMB HAEMOST, V13, P1028, DOI 10.1111/jth.12923
  26. Gandara E, 2013, THROMB HAEMOSTASIS, V110, P1172, DOI 10.1160/TH13-06-0488
  27. Gavilanes-Oleas FA, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e216
  28. Jiang QJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00876
  29. Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422
  30. Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201
  31. Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026
  32. Kearon C, 2015, ANN INTERN MED, V162, P27, DOI 10.7326/M14-1275
  33. KERNOHAN RJ, 1966, LANCET, V1, P621
  34. Khorana AA, 2018, J THROMB HAEMOST, V16, P1891, DOI 10.1111/jth.14219
  35. Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959
  36. Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232
  37. Lyman GH, 2015, J CLIN ONCOL, V33, P654, DOI 10.1200/JCO.2014.59.7351
  38. Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1
  39. Mukai M, 2018, J CARDIOL, V72, P89, DOI 10.1016/j.jjcc.2018.02.011
  40. Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444
  41. Piazza G, 2015, CLIN CHEM, V61, P313, DOI 10.1373/clinchem.2014.234088
  42. Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108
  43. Prandoni P, 2007, HAEMATOL-HEMATOL J, V92, P199, DOI 10.3324/haematol.10516
  44. Prins MH, 2018, BLOOD ADV, V2, P788, DOI 10.1182/bloodadvances.2018017160
  45. Puurunen MK, 2016, THROMB RES, V145, P27, DOI 10.1016/j.thromres.2016.06.033
  46. Raskob GE, 2014, THROMB HAEMOSTASIS, V112, P843, DOI 10.1160/TH14-08-0671
  47. Raskob GE, 2018, NEW ENGL J MED, V378, P615, DOI 10.1056/NEJMoa1711948
  48. Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029
  49. Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697
  50. Simes J, 2014, CIRCULATION, V130, P1062, DOI 10.1161/CIRCULATIONAHA.114.008828
  51. STEELE P, 1980, LANCET, V2, P1328
  52. Tosetto A, 2012, J THROMB HAEMOST, V10, P1019, DOI 10.1111/j.1538-7836.2012.04735.x
  53. Turpie AGG, 2017, RES PRACT THROMB HAE, V1, P1
  54. Venker BT, 2017, J ARTHROPLASTY, V32, P645, DOI 10.1016/j.arth.2016.09.033
  55. Volschan A, 2004, ARQ BRAS CARDIOL S1, V83, P1
  56. Weitz JI, 2017, NEW ENGL J MED, V376, P1211, DOI 10.1056/NEJMoa1700518
  57. Young AM, 2018, J CLIN ONCOL, V36, P2017, DOI 10.1200/JCO.2018.78.8034